Market Signal Briefing

Danaos Corporation remains a deep value play, boasting high profitability, strong earnings visibility, and a fortress balance sheet, despite a recent run-up. DAC's disciplined and opportunistic capital allocation would make Buffett proud, with a proven record of buying at cycle lows and focusing on immediately accretive transactions derisked through financing and chartering. Recent moves into dry bulk and the Alaska LNG partnership provide optionality and potential new earnings engines, while core containership operations remain resilient.

Celsius Holdings faces ongoing distribution disruptions tied to its Pepsi partnership and the Alani Nu acquisition transition. Management anticipates over 17% shelf space gains for CELH and 100% for Alani Nu, but execution risks remain due to past flavor launch missteps. The stock trades at just 4x forward sales, significantly discounted versus Monster Beverage, despite stronger growth prospects and recent sales outperformance.

Claritev Corporation (CTEV) Q4 2025 Earnings Call Prepared Remarks Transcript

February 24, 2026 04:49 ET  | Source: Shore Capital Stockbrokers Limited

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offereeCAB Payments Holdings Plc(c)        Name of the party to the offer with which exempt principal trader is connected:CAB Payments Holdings Plc(d)        Date dealing undertaken:23 February 2026(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?No 2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a)        Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/receivedOrdinaryPurchases126,33485p81.95pOrdinarySales126,98284.525p82.275p (b)        Derivatives transactions (other than option)

Class of relevant securityProduct description
e.g. CFDNature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit      (c)        Options transactions in respect of existing securities

(i)        Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType
e.g. American, European etc.Expiry dateOption money paid/ received per unit         (ii)        Exercising

Class of relevant securityProduct description
e.g. call optionNumber of securitiesExercise price per unit     (d)        Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing
e.g. subscription, conversionDetailsPrice per unit (if applicable)     The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
If there are no such agreements, arrangements or understandings, state “none”None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)        the voting rights of any relevant securities under any option; or
(ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”None

Date of disclosure:24 February 2026Contact name:Justin BallTelephone number:0207 601 6116 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

24 February 2026 - Fleet utilisation for January 2026 was 100%.   In Brazil, Safe Eurus, Safe Notos, and Safe Zephyrus continued to operate at full capacity in January, delivering near 100 % commercial uptime.

Key support today is an uptrend line from the January 7 main bottom at $55.48, coming in at $64.70. This is followed by a 50% level at $64.52.

Further down is a pair of 50% levels at $62.84 and $61.08. The major support and trend indicators are the 200-day moving average at $60.97 and the 50-day moving average at $60.43. The 50-day MA is slowly creeping up and is likely to cross to the strong side of the 200-day MA within a few days, which would be a bullish signal.

Iran Talks Thursday with the Clock Already Ticking Fundamentally, buyers continue to assess the risks to supply if there is direct military activity between the United States and Iran. In the meantime, talks centering on Iran’s nuclear program are expected to resume in Geneva on Thursday. The U.S. wants Iran to give up its nuclear program, but Iran has yet to yield to pressure, citing it as their right. They have also denied trying to develop an atomic weapon.

Last Thursday, President Trump said he has a 10-to-15-day window before he would consider bombing Iran. With the next meeting on Thursday, it’s possible that a U.S. attack could begin over the weekend if a deal or even the framework of a deal isn’t struck during this round of negotiations.

At this point, the bullish price action is being generated by aggressive traders hedging against the worst-case scenario — an actual disruption in oil supply. So far, no oil has been lost, but the recent rally suggests traders have taken about 6% to 10% of protection.

More evidence that the United States is moving closer to a showdown with Iran: Reuters reported that the State Department is pulling out non-essential government personnel and their families from the U.S. embassy in Beirut.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

-

Global consultancy to consolidate travel operations with Navan across more than a dozen markets

PALO ALTO, Calif.--(BUSINESS WIRE)--Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced it has been selected by Simon-Kucher, the world’s leading commercial growth and pricing consultancy, as its global travel partner. Simon-Kucher teams will now have access to Navan’s AI-powered travel management platform across more than a dozen markets, including in the North American, European, and APAC regions.

“Our work is increasingly global, and travel remains essential to how we collaborate with clients and with one another,” said Thomas Wohlan, Director of Travel Management at Simon-Kucher. “To support that at scale, we needed a modern travel platform that brings consistency across countries and simplifies the experience for our teams. Navan enables us to operate more efficiently on a single global platform, with the level of intelligence and support expected of a firm like ours.”

Through the partnership, Simon-Kucher will benefit from:

A modern booking experience: Leveraging Navan’s AI-assisted booking to reduce the average time to book a trip to under seven minutes and aiming to increase platform adoption to more than 95%. Optimized travel spend: Improving access to competitive travel inventory and fare options through Navan’s dynamic policy controls and unrivalled airline content. Emissions visibility and lower-impact travel choices: Providing consolidated reporting of travel-related emissions and offering lower-emission options, such as rail. Employee-level sustainability insights: Enabling dashboards for employees to view their travel footprint, while giving the firm deeper visibility into regional patterns. “For a global consultancy like Simon-Kucher, travel is the engine of the business, but the old way of managing it just slows people down,” said Michael Riegel, Chief Customer Officer at Navan. “Teams today expect their work tools to be as smart and intuitive as the apps they use in their personal lives. By moving to Navan, Simon-Kucher is gaining an AI-powered platform that makes travel easy for its teams.”

The agreement with Simon-Kucher reinforces Navan’s growth in the enterprise segment, joining new customers Yahoo, Axel Springer, and Frasers Group.

About Simon-Kucher

Simon-Kucher is a global consultancy with more than 2,000 employees in 30+ countries. Its sole focus is on unlocking better growth that drives measurable revenue and profit for its clients. They achieve this by optimizing every lever of their commercial strategy – product, price, innovation, marketing, and sales – based on deep insights into what customers want and value. With over 40 years of experience in monetization topics of all kinds, it is regarded as the world’s leading pricing and growth specialist.

About Navan

Navan (NASDAQ: NAVN) is the global AI-powered business travel and expense platform that makes travel easy for frequent travelers. From finding flights and hotels, to automating expense reconciliation, with 24/7 support along the way, Navan delivers an intuitive experience travelers love and finance teams rely on. See how Navan customers benefit and learn more at navan.com.

Forward Looking Statements

All statements in this press release other than statements of historical fact could be deemed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will,” or similar expressions. Such statements are subject to risks, uncertainties and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. These risks and other factors include the risks described under the caption “Risk Factors” in Navan’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on December 15, 2025 and in other reports Navan files from time to time with the SEC. Except as required by law, Navan undertakes no obligation, and does not intend, to update these forward-looking statements.

More News From Navan

Back to Newsroom

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

-Earnings Webinar Scheduled for 6:00 a.m. ET on March 17, 2026-

, /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, today announced that it will report its fourth quarter and fiscal year 2025 unaudited financial results on Tuesday, March 17, 2026, before the open of U.S. markets.

The Company's management will host a Tencent Meeting Webinar at 6:00 a.m. U.S. Eastern Time on March 17, 2026 (6:00 p.m. Beijing/Hong Kong time on March 17, 2026), to review and discuss the Company's business and financial performance.

For participants who wish to join the webinar, please complete the online registration in advance using the links provided below. Upon registration, participants will receive an email with webinar access information, including meeting ID, meeting link, dial-in numbers, and a unique attendee ID to join the webinar.

Participant Online Registration

A live webcast of the webinar will be accessible at https://ir.huya.com, and a replay of the webcast will be available following the session.

[1] For the purpose of this announcement only, Chinese Mainland excludes the Hong Kong Special Administrative Region, the Macao Special Administrative Region of the People's Republic of China, and Taiwan.

About HUYA Inc.

HUYA Inc. is a leading game-related entertainment and services provider. Huya delivers dynamic live streaming and video content and a rich array of services spanning games, e-sports, and other interactive entertainment genres to a large, highly engaged community of game enthusiasts. Huya has cultivated a robust entertainment ecosystem powered by AI and other advanced technologies, serving users and partners across the gaming universe, including game companies, e-sports tournament organizers, broadcasters and talent agencies. Leveraging this strong foundation, Huya has also expanded into innovative game-related services, such as game distribution, in-game item sales, advertising and more. Huya continues to extend its footprint in China and abroad, meeting the evolving needs of gamers, content creators, and industry partners worldwide.

For more information, please visit: https://ir.huya.com.

For investor and media inquiries, please contact:

In China:

HUYA Inc.
Investor Relations
Tel: +86-20-2290-7829
E-mail: [email protected]

Piacente Financial Communications
Jenny Cai
Tel: +86-10-6508-0677
E-mail: [email protected]

In the United States:

Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: [email protected]

SOURCE HUYA Inc.

A Netflix logo is displayed at the Lucca Comics & Games 2025 event in Lucca, Italy, October 31, 2025. REUTERS/Claudia Greco/File Photo Purchase Licensing Rights, opens new tab

LONDON, Feb 24 (Reuters) - Britain said on Tuesday Netflix (NFLX.O), opens new tab, Amazon Prime Video (AMZN.O), opens new tab, Disney+ (DIS.N), opens new tab and other streamers would be required to follow the same rules on content and accessibility as traditional broadcasters like the BBC.

Two-thirds of households subscribe to at least one major streamer, with 85% of people using an on-demand service each month, compared to 67% who watch live TV, the government said.

Read about innovative ideas and the people working on solutions to global crises with the Reuters Beacon newsletter. Sign up here.

Bringing the services into the scope of regulator Ofcom's broadcasting code would protect audiences from harmful content, and ensure the provision of accessibility services like subtitles, it said.

Streaming services with more than 500,000 UK users will have to adhere to the new standards, which include ensuring news is reported accurately and impartially and audiences are protected against harmful or offensive material.

Ofcom will have powers to investigate and take action where they consider there has been a breach of the code, it said.

Reporting by Paul Sandle; editing by William James

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Viridien

A French société anonyme
with a share capital of € 7,187,279
Registered office: 27 avenue Carnot, 91300 Massy, France
Evry Trade and Companies Register 969 202 241

Information on the total number of voting rights and shares

Pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial markets authority
(AMF- Autorité des Marchés Financiers)

Date of the informationTotal number of issued sharesNumber of actual voting rights*Number of theoretical voting rights**January 31, 20267,187,2797,212,1127,212,361 *         All of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than two years, which have double voting rights.

**         Pursuant to Article 223-11 of the General Regulation of the French Financial markets authority, the number of theoretical voting rights is calculated based on the shares having either single or double voting rights, including treasury shares which are deprived of voting rights.

2026.01.31_information mensuelle AMF ENG

(CSE: URAI / OTC: URAIF / FSE: 3QG0)
[email protected]

Highlights

The Company is processing and evaluating up to 10 patents against trade secret strategies Proprietary methods support non-contact monitoring without cameras, wearables or specialist hardware New capabilities expand commercial applications across healthcare, aged care and smart living, making comprehensive monitoring more affordable and from a single ecosystem , /PRNewswire/ - Inturai Ventures Corp. (the "Company") (CSE: URAI) (OTC: URAIF) (FSE: 3QG0) is pleased to provide a technical update on its spatial intelligence platform and outlines the intellectual property framework established to protect its internally developed processes and proprietary methods.

Inturai has developed a set of internally developed software processes that analyse existing Wi-Fi and radio frequency signals to derive information on movement, presence and activity within physical environments. These processes operate without the use of cameras or dedicated sensing hardware and are designed for deployment using standard Wi-Fi infrastructure.

To secure these technology advances, the Company has established an intellectual property strategy focused on protecting its proprietary methods and associated technologies across three defined areas corresponding to the core functional layers of the platform.

Core Sensing and Signal Intelligence

At the foundational level, Inturai has developed proprietary methods for processing and interpreting wireless signal behaviour to generate spatial awareness. These internally developed processes focus on extracting environmental information from radio frequency data and enable functions such as motion detection, presence identification and location estimation.

Protected technologies in this area are intended to secure the signal-processing and interpretation methods that allow these capabilities to be delivered without additional hardware, supporting scalable and cost-efficient deployment.

Health and Human Context Sensing

Building on the core sensing layer, Inturai has internally developed processes for analysing wireless signal data to infer human-related patterns. These proprietary methods support non-contact and non-intrusive assessment of general activity and behavioural context relevant to healthcare, aged care and smart living environments such as sleep quality and heart rate.

Protected technologies in this category focus on enabling innovative, affordable continuous monitoring, while avoiding visual data capture and reducing privacy and regulatory complexity.

Defence and Security Applications

The Company has extended its proprietary methods for use in defence, policing and security environments where visibility may be limited or obstructed. Internally developed processes in this area relate to identifying and interpreting activity and movement within sensitive spaces using signal-based sensing techniques, solving problems these groups still face with beyond-line-of-sight awareness.

Protected technologies in this category are directed at securing the application of spatial intelligence methods in large-scale operational and security-related contexts, supporting situational awareness and safety outcomes such as presence, target health and activity profiling and large-scale monitoring for borders and field operations.

Inturai continues to pursue patent filings and related intellectual property protections to secure its protected technologies, reinforce long-term defensibility and support disciplined commercial deployment across healthcare, defence and security sectors.

Ed Clarke
Chief Executive Officer
Inturai Ventures Corp.
[email protected]
+1 (604) 339-0339

About Inturai Ventures

Inturai Ventures is advancing intelligent environments with cutting-edge AI technologies, transforming industries such as healthcare, military, smart homes, and industrial applications. For more information, visit www.inturai.com.

This document contains certain forward-looking statements that are based on assumptions as of the date of this news release. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. All such forward-looking statements involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company's control. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect and the actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

SOURCE INTURAI VENTURES CORP.

By Reuters

February 24, 20268:21 AM UTCUpdated 8 mins ago

The blue Ford oval logo is displayed on the new Ford World Headquarters in Dearborn, Michigan, U.S. November 16, 2025. REUTERS/Rebecca Cook/File Photo Purchase Licensing Rights, opens new tab

CompaniesFeb 24 (Reuters) - Ford (F.N), opens new tab is recalling 412,774 Explorer vehicles in the U.S., citing an issue with rear suspension toe links, which may fracture, leading to a loss of steering control, the U.S. National Highway Traffic Safety Administration said on Tuesday.

Stay up to date with the latest news, trends and innovations that are driving the global automotive industry with the Reuters Auto File newsletter. Sign up here.

Reporting by Rajveer Singh Pardesi in Bengaluru; Editing by Rashmi Aich

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Construction of its 1GWh LFP Battery Cell Mega Factory to Begin in February 2026.

SUBOTICA, Serbia & LUXEMBOURG--(BUSINESS WIRE)--ElevenEs has completed the first closing of its Series B investment round, backed by Caterpillar Venture Capital Inc., a wholly owned subsidiary of Caterpillar Inc. (NYSE: CAT) - the world’s leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives. Additionally, an affiliate of BST (HK) Ltd., a leading Hong Kong-based commodity trading house, participated in the round.

Construction of the ElevenEs 1GWh LFP Battery Cell Mega Factory to Begin in February 2026.

Share This transaction represents a significant milestone in the future of European battery manufacturing as the proceeds will be used for the initial phases of infrastructure and equipment toward the planned 1GWh Mega-Factory, with construction starting in February 2026. The first battery cell deliveries are expected in 2027. This project positions ElevenEs at the forefront of the global energy transition and marks a significant step forward in delivering advanced electrified solutions from European sources.

ElevenEs is scaling its proprietary Lithium Iron Phosphate (LFP) Edge battery technology to meet the rigorous performance demands of industrial vehicles and equipment in mining, construction, rail and marine segments, in addition to battery electric vehicles (BEVs), buses, trucks and battery energy storage systems (BESS). The collaboration with Caterpillar strengthens ElevenEs’ mission to deliver robust, reliable battery solutions for customers worldwide.

After completing its industrial pilot battery manufacturing plant in 2023, ElevenEs will transition from pilot operations to mass-scale production, specializing in high-performance LFP blade prismatic cells. The new factory complex will feature nearly 25,000 square meters of state-of-the-art production facilities.

The ElevenEs’ project is building a high-tech ecosystem in Serbia that will employ more than 350 people, significantly increasing its existing team of over 110 international experts.

“In a crucial moment for the European battery industry, the investment from Caterpillar will support ElevenEs in its steps to advance LFP technology, expand global presence, scale operations to a 1GWh production facility, and position its European market leadership,” said Nemanja Mikać, Founder and CEO of ElevenEs.

“We look forward to developing advanced LFP solutions for various industrial applications, continue innovating on battery energy storage systems and support Caterpillar’s focus on energy solutions.”

Key project data:

- Location: Subotica, Serbia

- Facility Footprint (Phase 1): ~25,000 m²

- Technology: LFP Edge (Lithium Iron Phosphate) – Cobalt and Nickel-free

- Capacity (Mega Factory): 1 GWh annually

- Workforce: 350+

- Safety: State-of-the-art automated facility handling stable, non-volatile LFP materials

- Sustainability: Lower carbon footprint manufacturing and a facility design optimized for low waste and circularity

About ElevenEs

ElevenEs is a battery technology company committed to the industrialization of lithium iron phosphate (LFP) battery cells, packs and systems for electric mobility and energy storage applications. Incorporated in Luxembourg with headquarters and main operations in Serbia, ElevenEs focuses on delivering safe, sustainable, and high-performance battery solutions for European and North American markets.

Learn more at www.elevenes.com

This biotech powerhouse could maintain its strength for the long term.

Biotech companies are all about innovation. These players are developing and using cutting-edge technologies to address a variety of diseases, and in many cases, their efforts are leading to game-changing products for patients. You can invest in them during the earliest stages of their story, and if they're successful, score an enormous win over time.

That involves some risk, though, as candidates may not always be successful -- and setbacks could weigh heavily on stock performance. So how can you benefit from the innovation of biotech, but at a lower risk level? By choosing a company that's further along in its growth story and has brought products to market, and at the same time continues to innovate.

Let's check out one that fits the bill. In fact, it's the ultimate biotech stock to buy with $500 right now.

Image source: Getty Images.

A market leader This biotech company is Vertex Pharmaceuticals (VRTX +0.89%), the world's leading player in the cystic fibrosis (CF) treatment market. Vertex has changed the lives of CF patients and their families over the past several years. The company won approval for its first CF drug in 2012 and, since then, has continued to add to the portfolio, with the ability to now treat about 90% of the CF patient population.

Vertex's CF drugs are designed to fix a faulty protein made by the CFTR gene -- since genetic mutations are involved in this disease, it's challenging to develop one drug to handle every case. Now, Vertex's treatments can address most, but the company hasn't stopped there. It's working on a candidate to treat the cases that can't be helped by its current drugs. This ongoing innovation, as well as strong intellectual property, should fuel Vertex's leadership and growth in the years to come.

Today's Change

(

0.89

%) $

4.25

Current Price

$

481.15

New growth drivers On top of this, Vertex has two new growth drivers. The company won approval for Casgevy for blood disorders and Journavx for pain management in 2023 and 2025, respectively. These launches are ongoing, and trends are very positive. Casgevy is a gene editing treatment requiring a months-long process, so it's normal that this product takes a while to start delivering growth -- but now may be the moment shareholders were waiting for. Vertex expects non-CF products to bring in at least $500 million in revenue this year.

The company has called both products blockbuster opportunities, so we could be in the very early stages of this growth story right now. And Vertex forecasts as much as $13.1 billion in total revenue this year as the CF portfolio continues to deliver gains.

This leadership and ongoing innovation in CF, as well as new products, position Vertex for many years of strength -- and that's why it's the ultimate biotech to buy with $500 right now.

UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo NordiskIn a placebo-controlled phase 2 trial in Chinese people with overweight or obesity, UBT251 led to a statistically significant mean weight loss of up to 19.7% after 24 weeksUBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies. Guangdong, China and Bagsværd, Denmark, 24 February 2026 – The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced topline results from a Chinese phase 2 trial of UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon (triple G).

UBT251 is being jointly developed by TUL’s wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd. (United Biotechnology) and Novo Nordisk under an agreement signed in March 2025. United Biotechnology is responsible for development in Chinese mainland, Hong Kong, Macau and Taiwan, while Novo Nordisk is responsible for development in the rest of the world.

The trial, conducted by United Biotechnology, investigated the safety and efficacy of once-weekly injectable 2 mg, 4 mg and 6 mg doses of UBT251 compared to placebo in Chinese people with overweight or obesity. From a baseline mean body weight of 92.2 kg, the highest mean weight loss observed for people treated with UBT251 was 19.7% (-17.5 kg) compared to 2.0% (-1.6kg) in the placebo group after 24 weeks of treatment1.

Moreover, all dose groups of UBT251 showed statistically significant improvements relative to placebo on key secondary endpoints, including waist circumference, blood glucose, blood pressure and lipids.

In the trial, UBT251 appeared to have a safe and well-tolerated profile. The most common adverse events were gastrointestinal, and the vast majority were mild to moderate and diminished over time, consistent with incretin-based therapies.

“The success of the phase 2 clinical trial of UBT251 in China represents another significant milestone in TUL’s innovation-driven development,” said Mr Tsoi Hoi Shan, Chairman of TUL. “We will continue to focus on chronic diseases, including endocrine and metabolic disorders, accelerate the further development of UBT251, and strive to bring more high-quality treatment options to patients worldwide at the earliest opportunity.”

“We are very encouraged by these data from the trial in China, which demonstrate the potential of UBT251 and its differentiated clinical profile and safety and tolerability profile,” said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development at Novo Nordisk. “We look forward to reporting data from a global trial with UBT251 conducted by Novo Nordisk next year.”

Novo Nordisk recently initiated a global phase 1b/2a trial investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of different doses of UBT251 for up to 28 weeks in around 330 people living with overweight or obesity. Topline data from that trial is expected in 2027. Novo Nordisk also expects to initiate a phase 2 trial with UBT251 in people with type 2 diabetes in the second half of 2026.

United Biotechnology will present detailed data from the Chinese phase 2 trial at a medical congress later this year. Based on the results of this trial, the company is planning to initiate a phase 3 trial in Chinese patients with overweight or obesity.

About the Chinese phase 2 trial
This randomized, double-blind, placebo-controlled trial enrolled a total of 205 Chinese patients with obesity (BMI ≥ 28.0 kg/m²) or overweight (24.0 kg/m² ≤ BMI < 28.0 kg/m²) with at least one weight-related comorbidity. The baseline mean body weight of the patients was 92.2 kg, with a baseline mean BMI of 33.1 kg/m².

Patients were randomly assigned to receive weekly subcutaneous injections of UBT251 in doses of 2 mg, 4 mg, 6 mg, or placebo for 24 weeks.

The primary endpoint of the trial was the percentage change in body weight from baseline after 24 weeks of treatment.

About UBT251
UBT251 is a long-acting synthetic peptide triple agonist targeting the receptors for GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon.

In March 2025, United Biotechnology entered an exclusive license agreement with Novo Nordisk A/S for UBT251. Under the agreement, Novo Nordisk obtained exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture and commercialise UBT251. United Biotechnology retained the rights for UBT251 in Chinese mainland, Hong Kong, Macau and Taiwan.

About TUL and United Biotechnology
Founded in 1990, TUL (HKEX: 3933) is mainly engaged in the research and development, production and sales of pharmaceuticals, and ranks among the leading integrated pharmaceutical companies in China. TUL currently boasts seven production bases, covering intermediate products, bulk medicine, finished products, veterinary drugs, empty capsule casings, and medical devices, with the sales networks dotted across nearly 80 countries and regions. United Biotechnology, located in the Guangdong-Macao In-Depth Cooperation Zone in Hengqin, serves as the biopharmaceutical R&D headquarter of TUL. United Biotechnology focuses on the development of high-end biopharmaceuticals to treat major chronic diseases. For more information, please visit www.tul.com.cn.

About Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 68,800 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.

Contacts for further information:

Novo Nordisk Media: Ambre James-Brown
+45 3079 9289
[email protected] Liz Skrbkova (US)
+1 609 917 0632
[email protected] Nordisk Investors: Michael Novod
+45 3075 6050
[email protected] Martin Wiborg Rode
+45 3075 5956
[email protected] Meyer
+45 3079 6656
[email protected] Ung
+45 3077 6414
[email protected] Sho Togo Tullin
+45 3079 1471
[email protected] Alex Bruce
+45 3444 2613
[email protected] Frederik Taylor Pitter
+1 609 613 0568
[email protected] TUL Media: iPR Limited
Tina Law / Joann Fang
+852 2136 6185
[email protected] TUL Investors: Karen Yang / Sandy He /
Mercy Mo
+86 760 8713 3970/ 8713 3742/
8713 3724
[email protected]  1 Based on the efficacy estimand according to the trial protocol, regardless of dose modification

PR260224-UBT251

NVIDIA Corporation is set to report Q4 earnings, with consensus expecting 68% YoY revenue growth and potential for a modest beat. NVDA's growth rate is slowing compared to prior years, and market enthusiasm has tempered despite continued AI hardware leadership and profitability. Recent news includes a scaled-back $30B investment in OpenAI and a strategic but lower-margin entry into the PC notebook SoC market.

Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call Transcript

Nokia and AWS showcase industry-first agentic AI-powered network slicing with du and Orange

Industry-first intent-based 5G-Advanced slicing with agentic AI offers telecommunication providers with premium network slicing services that respond to real-world situations and enable autonomous intelligence.This breakthrough innovation inferences and leverages open Internet data, including traffic, events, locations, maps and operator data for network slicing business.du and Orange first to explore this innovative slicing solution that adapts automatically to support customer demand. Espoo, Finland – Nokia today announced a new collaboration with Amazon Web Services (AWS) to bring the first agentic AI-powered 5G-Advanced network slicing solution in a live 5G network. The intent-based 5G slicing innovation combines Nokia’s advanced network slicing with AWS AI platform technologies to empower telecommunication providers in delivering premium services precisely where and when they are needed. du and Orange are the first to explore the innovation in their respective networks.

Nokia's innovative AI slicing solution, powered by AWS, uses agentic AI to analyze real-world internet data, including locations, events, traffic, incidents, and maps, enabling telecommunications providers to deliver adaptive network slicing. This agentic AI-powered approach unlocks significant customer value across diverse applications and use cases by creating premium services that respond intelligently to dynamic conditions, ensuring optimal performance precisely where and when customers need it.

Furthermore, telecommunication providers can face challenges optimizing network performance during unpredictable events like traffic surges, emergencies or mass gatherings, which can result in suboptimal service quality and inefficient resource utilization. Autonomous network slicing intelligence dynamically adapts and manages even the most challenging traffic conditions across varied geographical areas.

Pallavi Mahajan, Chief Technology and AI Officer at Nokia commented: “This innovation marks a major milestone in the evolution of AI-native networks. By combining Nokia’s advanced network slicing capabilities with agentic AI, we are enabling operators to deliver premium, intent-based services that adapt dynamically to real-world conditions. Nokia is advancing connectivity by unlocking new value streams for telecommunication providers and supporting next-generation applications and differentiated services for enterprises, industries and consumers.”

“Network slicing has long promised to unlock new revenue streams for operators, but manual configuration and static policies have prevented end customers from accessing on-demand provisioning," said Amir Rao, Global Director, GTM & Telco Solutions at AWS. “By integrating agentic AI capabilities through Amazon Bedrock with Nokia’s application, operators can now deliver intelligent, context-aware network slicing that responds dynamically to real-world conditions from traffic surges to emergency situations. This transforms network slicing from a technical capability into a true business enabler, allowing operators to monetize their 5G investments through differentiated, premium services that adapt automatically to customer needs. Agentic Network Slicing is the beginning of an era that will enable telecommunications providers to enable real-time intent-based service provisioning for end customers.”

Agentic AI slicing for diverse applications and use cases
This agentic AI-powered 5G-Advanced network slicing innovation can be used for different use cases, including:

Intent-based enterprise and industrial slicing measures live network KPIs such as bitrate and latency and autonomously adjusts RAN policies to meet enterprise SLAs across campuses, business parks and city areas. The innovation enhances premium slicing services for critical applications in manufacturing, IoT, drones, smart cities, hospitals, energy, transportation and ports.On-demand slicing with agentic AI boosts network performance for selected 5G base stations. When activated by external data, this service provides first responders and public safety authorities with better network connectivity during emergencies. On-demand network slicing with agentic-AI preserves quality of service for premium 5G+ and FWA customers using gaming, streaming, XR, and AI applications in response to major traffic surges, weather conditions and environmental changes.Agentic AI for mass events provides much broader capacity availability during high-demand moments like concerts and sporting events. AI analyses network data, infers patterns, and sets slicing policies for scheduled events, optimizing premium 5G slicing for VIP spectators, payment applications, fan engagement, video broadcasting and operational crews in arenas, parks and conference centers. “We are excited to be among the first to pilot this groundbreaking solution on a live network. Agentic AI-powered slicing will allow us to deliver highly responsive, premium services to our customers, whether for critical enterprise applications or enhanced consumer experiences,” said Saleem Alblooshi, Chief Technology Officer at du.

“Orange is committed to driving innovation in 5G, and this experimentation demonstrates how AI can transform network operations. With intent-based slicing, we can anticipate customer needs and deliver tailored services that meet the demands of diverse use cases, from mission-critical to immersive entertainment,” commented Atoosa Hatefi, Director of Innovation in Radio and Environment, Orange.

Leveraging leading-edge technologies
Nokia’s agentic AI-powered solution on AWS introduces intent-based network slicing that continuously monitors network KPIs, infers real-world contextual data from multiple sources and automatically adjusts RAN policies to meet service-level agreements. The end-to-end advanced network slicing innovation across RAN-transport-core utilizes especially Nokia’s 5G AirScale base station, MantaRay SMO and Agentic AI modules, which are seamlessly integrated with the Amazon Bedrock Artificial Intelligence platform.

The integrated solution uses agentic AI to coordinate data analytics, inferencing, and RAN policies. These AI agents leverage open internet data—including events, timetables, incidents, traffic, locations, maps, and weather—for different network slicing use cases. The agentic AI modules operate in multiple modes: chatbot, on-demand, scheduled, and autonomous. All modules interact with Amazon Bedrock via APIs. Furthermore, applications and use cases powered by Agentic AIs are enhanced with Nokia’s Edge Slicing solution, bringing cloud applications and workloads directly to mobile users and devices over high-capacity, secure, and low-latency networks.

Amazon Bedrock enables intelligent network optimization by providing access to foundation models and the infrastructure to build specialized AI agents. These agents analyze historical RAN parameters alongside contextual data to optimize RAN, core, and transport layers for mobile networks. Using Amazon EKS Hybrid Nodes, telecommunications providers can deploy these agents and network workloads on their existing infrastructure while unifying Kubernetes management across cloud and edge environments, providing the flexibility and scalability needed for modern network operations

Nokia at Mobile World Congress 2026
Visitors to Nokia’s booth in Hall 3 at this year’s Mobile World Congress event will be able to see live demonstrations of Nokia’s slicing solution and the agentic AI-powered advanced network slicing innovation.

Multimedia, technical information, and related news 
Webpage: AirScale Radio Access 
Webpage: MantaRay SMO | Nokia.com
Webpage: Network slicing | Nokia.com
Webpage: Autonomous Networks | Nokia
Webpage: 5G edge slicing | Nokia.com

About Nokia
Nokia is a global leader in connectivity for the AI era. With expertise across fixed, mobile, and transport networks, we’re advancing connectivity to secure a brighter world.

About Amazon Web Services
Amazon Web Services (AWS) is guided by customer obsession, pace of innovation, commitment to operational excellence, and long-term thinking. By democratizing technology for nearly two decades and making cloud computing and generative AI accessible to organizations of every size and industry, AWS has built one of the fastest-growing enterprise technology businesses in history. Millions of customers trust AWS to accelerate innovation, transform their businesses, and shape the future. With the most comprehensive AI capabilities and global infrastructure footprint, AWS empowers builders to turn big ideas into reality. Learn more at aws.amazon.com and follow @AWSNewsroom. 

Media inquiries 
Nokia Press Office 
Email: [email protected]  

Follow us on social media 
LinkedIn X Instagram Facebook YouTube 

Collaboration aims to enhance greater efficiency, adaptability and user satisfaction across the commercial vehicle manufacturer's operations

, /PRNewswire/ -- Cognizant (Nasdaq: CTSH) has been chosen by one of the world's largest commercial vehicle manufacturers to transform and modernise its global workplace services. This multi-year partnership aims to leverage artificial intelligence and automation to enhance workplace operations across global factories and offices.

The initiative will see the utilization of Cognizant WorkNEXT™ - a modern, flexible digital fabric powered by AI to create an unparalleled workplace experience. Cognizant WorkNEXT™ helps organizations build adaptive, integrated and human-centric workplaces, driving experience reliability and embracing automation through the right balance of AI first, zero touch and high-touch support.

"We are proud to work with one of the world's largest commercial vehicle manufacturers as they embark on this AI‑led global transformation of their workplace services," said Ravi Kumar S, CEO Cognizant. "By applying artificial intelligence at the core of the workplace, alongside automation, human‑centric design and responsible governance, we are helping enable a more intelligent, resilient and future‑ready environment for Daimler Truck's global workforce."

About Cognizant

Cognizant (Nasdaq-100: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at www.cognizant.com or @cognizant

For more information, contact:

U.S.
Name: Gabrielle Gugliocciello
Email: [email protected] 

Europe / APAC
Name: Sarah Douglas
Email: [email protected] 

India
Name: Vipin Nair
Email: [email protected]

SOURCE Cognizant Technology Solutions

Surge in Memory Demand Drives 20.8% Increase in 4Q25 Revenue Compared to 4Q24 81.7% Expansion of 4Q25 Gross Profit Compared to 4Q24 4Q25 Net Earnings of NT$0.72 or US$0.02 per Basic Common Share or US$0.46 per Basic ADS Compared to 4Q24 Net Earnings of NT$0.32 or US$0.01 per Basic Common Share or US$0.20 per Basic ADS NT$1,554.8 Million or US$49.6 Million Net Free Cash Inflow for the full year 2025 Revenue Growth and Prudent CapEx Further Strengthen Financial Position with Cash and Cash Equivalents Balance of NT$14,858.9 Million or US$473.7 Million Distributed of NT$1.23 per Common Share by Capital Surplus Authorized by Board Pending Shareholder Approval at May 2026 AGM , /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 andNasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), today reported consolidated financial results for the fourth quarter and the full year ended December 31, 2025, with strong growth driven by improving demand for high-value memory solutions, particularly in datacenter and AI-related applications. All U.S. dollar figures cited in this press release are based on the exchange rate of NT$31.37 against US$1.00 as of December 31, 2025.

All the figures were prepared in accordance with Taiwan-International Financial Reporting Standards ("Taiwan-IFRS").

Revenue for the fourth quarter of 2025 was NT$6,521.1 million or US$207.9 million, an increase of 6.1% from NT$6,143.7 million or US$195.8 million in the third quarter of 2025 and an increase of 20.8% from NT$5,399.6 million or US$172.1 million for the same period in 2024. Revenue for the fiscal year ended December 31, 2025 was NT$23,932.9 million or US$762.9 million, an increase of 5.5% from NT$22,695.9 million or US$723.5 million for the fiscal year ended December 31, 2024.

Net non-operating expenses in the fourth quarter of 2025 was NT$23.8 million or US$0.8 million, compared to net non-operating income of NT$68.5 million or US$2.2 million in the third quarter of 2025, and net non-operating income of NT$154.6 million or US$4.9 million in the fourth quarter of 2024. The difference between the third quarter of 2025 is mainly due to the increase of share of loss of associates accounted for using equity method of NT$99 million or US$3.2 million. The difference between the fourth quarter of 2024 is mainly due to the increase of share of loss of associates accounted for using equity method of NT$110 million or US$3.5 million, the decrease of foreign exchange gains of NT$53 million or US$1.7 million and the increase of interest expense of NT$11 million or US$0.4 million.

Net non-operating expenses of the Company for the fiscal year ended December 31, 2025 was NT$555.4 million or US$17.7 million, compared to net non-operating income of NT$373.1 million or US$11.9 million for the fiscal year ended December 31, 2024. The difference is mainly due to the adverse impact on the foreign exchange of NT$703 million or US$22.4 million from the foreign exchange gains of NT$243 million or US$7.7 million in 2024 to the foreign exchange losses of NT$460 million or US$14.7 million in 2025, the adverse impact on share of associates accounted for using equity method of NT$146 million or US$4.7 million from the share of profit of associates accounted for using equity method of NT$3 million or US$0.1 million in 2024 to the share of loss of associates accounted for using equity method of NT$143 million or US$4.6 million in 2025 and the gain on disposal of non-current assets held for sale of NT$72 million or US$2.3 million in 2024.

Net profit attributable to equity holders of the Company for the fourth quarter of 2025 was NT$499.7 million or US$15.9 million, and NT$0.72 or US$0.02 per basic common share, as compared to NT$352.2 million or US$11.2 million, and NT$0.50 or US$0.02 per basic common share in the third quarter of 2025. This compares to NT$232.2 million or US$7.4 million, and NT$0.32 or US$0.01 per basic common share in the fourth quarter of 2024. Net earnings for the fourth quarter of 2025 were US$0.46 per basic ADS, compared to US$0.32 per basic ADS for the third quarter of 2025 and US$0.20 per basic ADS in the fourth quarter of 2024.

Net profit attributable to equity holders of the Company for the fiscal year ended December 31, 2025 was NT$495.1 million or US$15.8 million, and NT$0.70 or US$0.02 per basic common share, compared to net profit attributable to equity holders of the Company for the fiscal year ended December 31, 2024 was NT$1,420.0 million or US$45.3 million, and NT$1.95 or US$0.06 per basic common share. Net earnings for the fiscal year ended December 31, 2025 were US$0.44 per basic ADS compared to US$1.24 per basic ADS for the fiscal year ended December 31, 2024.

Net free cash flow for the full year 2025 was NT$1,554.8 million or US$49.6 million with a strong balance of cash and cash equivalents of NT$14,858.9 million or US$473.7 million.

Fourth Quarter and Full Year 2025 Investor Conference Call / Webcast Details

Date: Tuesday, February 24, 2026
Time: 3:00PM Taiwan (2:00AM New York)
Dial-In: +886-2-33961191
Password: 1048024 #
Webcast and Replay: https://www.chipmos.com/chinese/ir/info2.aspx
Replay: Starts approximately 2 hours after the live call ends

Language: MandarinNote: A transcript will be provided on the Company's website in English following the conference call to help ensure transparency, and to facilitate a better understanding of the Company's financial results and operating environment.

About ChipMOS TECHNOLOGIES INC.:

ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 andNasdaq: IMOS) (www.chipmos.com) is an industry leading provider of outsourced semiconductor assembly and test services. With advanced facilities in Hsinchu Science Park, Hsinchu Industrial Park and Southern Taiwan Science Park in Taiwan, ChipMOS is known for its track record of excellence and history of innovation. The Company provides end-to-end assembly and test services to leading fabless semiconductor companies, integrated device manufacturers and independent semiconductor foundries serving virtually all end markets worldwide.

Forward-Looking Statements

This press release may contain certain forward-looking statements. These forward-looking statements may be identified by words such as 'believes,' 'expects,' 'anticipates,' 'projects,' 'intends,' 'should,' 'seeks,' 'estimates,' 'future' or similar expressions or by discussion of, among other things, strategies, goals, plans or intentions. These statements may include financial projections and estimates and their underlying assumptions, statements regarding current macroeconomic conditions, including the impacts of high inflation, foreign exchange rates and risk of recession, on demand for our  products, consumer confidence and financial markets generally; changes in trade regulations, policies, and agreements and  the imposition of tariffs that affect our products or operations, including potential new tariffs that may be imposed and our  ability to mitigate with respect to future operations, products and services, and statements regarding future performance.  Actual results may differ materially in the future from those reflected in forward-looking statements contained in this document, based on a number of important factors and risks, which are more specifically identified in the Company's most recent U.S. Securities and Exchange Commission (the "SEC") filings. Further information regarding these risks, uncertainties and other factors are included in the Company's most recent Annual Report on Form 20-F filed with the SEC and in its other filings with the SEC.

Contacts:

In Taiwan

Jesse Huang

ChipMOS TECHNOLOGIES INC.

+886-6-5052388 ext. 7715

[email protected] 

In the U.S.

David Pasquale

Global IR Partners

+1-914-337-8801

[email protected] 

SOURCE ChipMOS TECHNOLOGIES INC.

PRESS RELEASE                                        

Share Buyback Transaction Details February 19 – February 23, 2026

Alphen aan den Rijn – February 24, 2026 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 130,851 of its own ordinary shares in the period from February 19, 2026, up to and including February 23, 2026, for €8.1 million and at an average share price of €61.90.

The previously disclosed third-party agreement to repurchase €200 million in shares starting November 6, 2025, up to and including February 23, 2026, has hereby been fulfilled.

The cumulative amounts repurchased in the year to date are as follows:

Share Buyback 2026

PeriodCumulative shares repurchased in period Total consideration
(€ million)Average share price
(€)2026 to date 1,318,03199.975.79 Shares repurchased are added to and held as treasury shares and will be used for capital reduction purposes through share cancelation.

Further information is available on our website:

Download the share buyback transactions excel sheet for detailed individual transaction information.Weekly reports on the progress of our share repurchases.Overview of share buyback programs. For more information about Wolters Kluwer, please visit: www.wolterskluwer.com.

###

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information solutions, software and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,900 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX, Euro Stoxx 50 and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

MediaInvestors/AnalystsStefan KloetMeg GeldensAssociate DirectorVice PresidentGlobal CommunicationsInvestor Relations  [email protected]@wolterskluwer.com Forward-looking Statements and Other Important Legal Information
This report contains forward-looking statements. These statements may be identified by words such as “expect”, “should”, “could”, “shall” and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; conditions created by pandemics; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer’s businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Elements of this press release contain or may contain inside information about Wolters Kluwer within the meaning of Article 7(1) of the Market Abuse Regulation (596/2014/EU). Trademarks referenced are owned by Wolters Kluwer N.V. and its subsidiaries and may be registered in various countries.

2026.02.24 Share Buyback Transactions Feb 19 - Feb 23 2026

UKRAINE - 2022/01/23: In this photo illustration, a Vir Biotechnology logo is seen on a smartphone and a computer screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

SOPA Images/LightRocket via Getty Images

Vir Biotechnology (VIR) is experiencing a surge of +58% pre-market due to a significant strategic partnership with Astellas concerning its prostate cancer treatment, VIR-5500, along with encouraging Phase 1 results. This information, combined with an impressive revenue exceedance, is fostering considerable optimistic sentiment. Could this event lead to a fundamental re-evaluation of the stock?

This represents a fundamental, long-term driving force. The alliance with Astellas not only secures $335M in upfront/near-term payments along with potential milestones reaching $1.37B, but it also endorses Vir's T-cell engager platform.

The agreement lengthens Vir's cash runway through Q2 2028, eliminating funding concerns.Phase 1 results for VIR-5500 indicated a promising 45% objective response rate among evaluable patients.The collaboration mitigates risks associated with the development and commercialization of a key oncology asset.However, here’s the intriguing aspect: You are reading about this 58% movement post-factum. The market has already incorporated this information. To identify the next potential winner before it becomes news, you need to rely on predictive indicators, not just alerts. High Quality Portfolio has highlighted 5 new opportunities that have yet to experience a surge.

Playbook On Market OpenThe session will witness a clash between shifts in long-term strategies and short-term profit-taking following a significant gap up. Observe the conviction from institutional investors against the fading enthusiasm from retail investors.

Maintain initial pre-market support levels for continued bullish momentum.Keep an eye on key psychological price points; break signals indicate substantial profit-taking.High volume during the opening drive that upholds highs is bullish; excessive reversal volume serves as a warning sign.VerdictBUY THE OPEN (Conditional): If VIR consolidates and stays above $11.50 within the first 30 minutes, anticipate a breakout, and go ahead and BUY THE OPEN. However, if $11.50 falls with volume, FADE THE GAP.

MORE FOR YOU

Grasping price actions can provide you with an advantage. See more.

Want to ensure you never miss the analysis on VIR’s forthcoming moves? Stay informed with Upcoming Events and Latest Analyses

That’s all for now, but there's much more to consider when evaluating a stock from a long-term investment perspective. We simplify this through our Investment Highlights

Portfolios Over Individual Stock PicksWhile individual stocks can rise or fall dramatically, one essential factor remains: maintaining your investment. A well-structured portfolio can support you in staying invested, capturing gains, and minimizing the risks tied to any single stock.

Why accept average market returns? The Trefis High Quality (HQ) Portfolio invests in a varied selection of 30 stocks that have collectively provided higher returns with reduced volatility compared to broader market indices. Uncover the methodology that leads to these steadier, superior returns by reviewing the HQ Portfolio performance data.

Tesla's Optimus Gen 3 robot has proven advanced dexterity and meaningful progress in achieving new degrees of freedom.

For much of its history, Tesla (TSLA 3.02%) was known for its lineup of electric vehicles (EV) and energy storage products. But over the last several years, CEO Elon Musk has been sharing his vision to transform the company from a pioneer of the sustainable energy movement into a technology-enabled services business driven by artificial intelligence (AI).

At the forefront of this mission is Tesla's humanoid robot, Optimus. Musk is so serious about Optimus' potential that he's made the executive decision to scale down production of the models S and X vehicles and repurpose Tesla's Fremont factory into a manufacturing center for Optimus.

Let's explore what's at stake with Optimus in 2026. With Tesla essentially mortgaging its future on next-generation services, is now the time to buy the stock before AI fuels its next parabolic run?

Today's Change

(

-3.02

%) $

-12.42

Current Price

$

399.40

What can Tesla Optimus do? Tesla has been building, testing, and iterating Optimus for many years. In its current form, the humanoid is known as Optimus Gen 3.

In marketing videos, Tesla claims that Optimus has learned fine motor skills given its ability to handle delicate objects such as tearing paper towels, opening a cabinet, or folding laundry.

In addition, Tesla has published videos of Optimus demonstrating advanced dexterity -- with an ability to catch moving objects tossed in its general direction, as well as learning how to walk on uneven terrain.

Image source: Tesla.

When will Tesla Optimus be available? During Tesla's fourth-quarter earnings call, Musk said that his long-term goal is to produce 1 million Optimus bots per year at the Fremont factory.

With that said, Musk tempered expectations by telling investors that even with Optimus' advances, the humanoid remains in a research and development (R&D) phase. Besides the lab, Optimus is only deployed within Tesla's own factories so that it can watch, observe, and learn how to complete basic tasks.

Musk hinted that production of Optimus won't occur until "probably the end of this year."

Is Tesla's valuation justified? As of this writing (Feb. 18), Tesla boasts a market capitalization of $1.6 trillion. From a valuation perspective, the company trades at a forward price-to-earnings (P/E) multiple of 202. Using Wall Street's consensus earnings per share (EPS) estimate of $4.05 for 2028, Tesla still trades at 103 times its projected earnings two years from now.

It's easy to say that Tesla stock is already priced to perfection and that buying shares today requires paying a premium. But a contrarian might say Tesla stock is undervalued because no company in history has ever successfully deployed physical AI at a global scale.

In other words, since there's nothing to benchmark Optimus against, it's impossible to know how big Tesla's robotics business could truly become.

Optimus remains an extremely asymmetric bet. If Tesla executes on this vision, the stock could soar to new highs rather easily. But if the product flops or struggles to scale, then Tesla stock could be due for a meaningful de-rating.

Against this backdrop, I would not buy Tesla stock today purely on the hype that Optimus will transform the company by the end of the year. In reality, it will take years -- or even decades -- before Optimus adds additional trillions of value to Tesla in the long run.